Drugs / NTM-1633
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03603665 | Sep 2018 → Jun 2019 | botulism | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NTM-1633 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03603665 ↗ |
| Route | Intravenous | “Administered as a single intravenous infusion of NTM-1633 over one hour.” NCT03603665 ↗ |